Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of January 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing primarily serves to distribute press releases regarding recent corporate activities and financing arrangements.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, or existing debt levels. The only quantifiable financial metric disclosed is a new credit facility:
- New Line of Credit: Aggregate amount of RMB 1 billion signed with Ping An and Xiamen International Banks.
Material Changes
There are no comparative financial statements or period-over-period changes disclosed in this document. The material change noted is the execution of the RMB 1 billion line of credit agreements, which represents a new liquidity source for the company.
Guidance, Outlook, and Management Commentary
The filing includes three press releases as exhibits:
- Announcement of the RMB 1 billion line of credit agreements.
- Participation in the 13th Beijing International Finance Expo.
- Launch of a nationwide investor education seminar.
The filing text does not contain specific forward-looking guidance, risk factors, or management commentary beyond the titles of these press releases.
Investor Verification Checklist
- Verify the terms and conditions of the RMB 1 billion credit facility with Ping An and Xiamen International Banks.
- Confirm the company's current total debt load to assess the impact of the new credit line.
- Review the full text of the press releases (Exhibits 99.1, 99.2, and 99.3) for details on the investor education seminar and expo outcomes.
- Note that the company name in the metadata ("Akso Health Group") differs from the registrant name in the filing ("Hexindai Inc."); verify the correct entity identity.